Skip to main content

Table 2 Procedural and device data of the included patients in the study

From: Long-term outcomes of percutaneous closure of ventricular septal defects in children using different devices: A single centre experience from Egypt

Parameter

Value*

n (%) or median (IQR)

Angiographic Defect diameter (mm)

6.4 (4.5–7.8)

Procedural time (in minutes)

118 (90–125)

Fluoroscopy time (in minutes)

23.5 (19-45.5)

Pulmonary artery mean pressure (mmHg)

20.5 (17.1–23.4)

Approach

• Antegrade

40 (53.33)

• Retrograde

35 (46.67)

Echocardiographic

guidance:

• TEE

64 (85.3)

• TTE

11 (14.7)

Device size

8 (6–10)

Types of Used Occluders

• Pfm Nit-Occlud Leˆ VSD Coil

32 (42.7)

• Hyperion™VSD Muscular Occluder

21 (28)

• Amplatzer Muscular Occluder (AMO)

8 (10.7)

• Amplatzer Duct Occluder (ADO I)

11 (14.7)

• Amplatzer Duct Occluder (ADO II)

1 (1.3)

• Occlutech Muscular VSD Occluder

2 (2.7)

Occluders used for Each VSD type

Perimembranous

39 (52)

Coil

26 (66.7)

Hyperion

6 (15.4)

ADO I

6 (15.4)

ADO II

1 (2.6)

Muscular

25(33.3)

AMO

8 (32)

Hyperion

15 (60)

Occlutech

2 (8)

Residual

11(14.7)

Coils

6 (54.5)

ADO I

5 (45.5)

  1. ADO: Amplatzer duct occluder, AMO: Amplatzer Muscular Occluder, TEE: transesophageal echocardiography; TTE: transthoracic echocardiography; VSD; ventricular septal defect
  2. *Data are expressed as mean ± SD or median (Interquartile range) or number (Percentage)